China Pharma Holdings (CPHI) Share-based Compensation (2010 - 2014)
China Pharma Holdings (CPHI) reported Share-based Compensation of $128024.0 for Q1 2014, down 43.47% on a YoY basis from $226490.0 in Q1 2013, and up 156.53% quarter-over-quarter from -$226490.0 in Q2 2013.
China Pharma Holdings (CPHI) Share-based Compensation (2010 - 2014) Analysis & Trends
China Pharma Holdings has reported Share-based Compensation for 5 years, with the latest figure at $128024.0 in Q1 2014.
- For the quarter ending Q1 2014, Share-based Compensation fell 43.47% year-over-year to $128024.0; the trailing twelve-month figure through Dec 2021 stood at $128024.0 (changed N/A YoY), and the FY2022 full-year result was $78270.0, up 413.48% from the prior year.
- Share-based Compensation for Q1 2014 stood at $128024.0, up from -$226490.0 in the prior quarter.
- The five-year high for Share-based Compensation was $226490.0 in Q1 2013, with the low at -$226490.0 in Q2 2013.
- Historically, Share-based Compensation has averaged $53658.5 across 5 years, with a median of $57109.0 in 2011.
- The largest YoY upside for Share-based Compensation was 300.95% in 2013 against a maximum downside of 365.73% in 2013.
- China Pharma Holdings' Share-based Compensation stood at $63829.0 in 2010, then slipped by 10.53% to $57109.0 in 2011, then surged by 49.24% to $85232.0 in 2012, then tumbled by 365.73% to -$226490.0 in 2013, then jumped by 156.53% to $128024.0 in 2014.
- The last three Share-based Compensation figures came in at $128024.0 (Q1 2014), -$226490.0 (Q2 2013), and $226490.0 (Q1 2013), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 128,024.00 |
| Mar 31, 2014 | 128,024.00 |
| Jun 30, 2013 | -226,490.00 |
| Jun 30, 2013 | -226,490.00 |
| Mar 31, 2013 | 226,490.00 |
| Mar 31, 2013 | 226,490.00 |
| Jun 30, 2012 | 85,232.00 |
| Jun 30, 2012 | 85,232.00 |
| Mar 31, 2012 | 56,489.00 |
| Mar 31, 2012 | 56,489.00 |
| Dec 31, 2011 | 57,109.00 |
| Dec 31, 2011 | 57,109.00 |
| Sep 30, 2011 | 57,109.00 |
| Sep 30, 2011 | 57,109.00 |
| Jun 30, 2011 | 40,067.00 |
| Jun 30, 2011 | 40,067.00 |
| Mar 31, 2011 | 41,898.00 |
| Mar 31, 2011 | 41,898.00 |
| Dec 31, 2010 | 63,829.00 |
| Dec 31, 2010 | 63,829.00 |